Show Stocks and Investing Publications • Tue, August 13, 2024
David Westenberg Maintained (AKYA) at Buy with Decreased Target to $4 on, Aug 13th, 2024
berg-maintained-akya-at-buy-with-decreased-target-to-4-on-aug-13th-2024.html
Stocks and Investing on Mon, Oct 28th, 2024David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $6 to $4 on, Aug 13th, 2024.
David has made no other calls on AKYA in the last 4 months.
There are 5 other peers that have a rating on AKYA. Out of the 5 peers that are also analyzing AKYA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mark Massaro of "BTIG" Downgraded from Strong Buy to Hold on, Tuesday, August 6th, 2024
- Rachel Vatnsdal of "JP Morgan" Downgraded from Buy to Hold on, Tuesday, August 6th, 2024
- Tejas Savant of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $3 on, Tuesday, August 6th, 2024
These are the ratings of the 2 analyists that currently disagree with David
- Bill Bonello of "Craig-Hallum" Maintained at Strong Buy with Decreased Target to $7 on, Tuesday, August 6th, 2024
- Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, May 14th, 2024